Journal profile · Ophthalmology
Eye
ISSN 0950-222X · eISSN 1476-5454 · Springer Nature · ENGLAND · Monthly · Founded 1987
Eye: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.42; hybrid open access; APC about USD 3,590; median 67 days to acceptance (178 articles, last 24 months); community-reported acceptance: easy; 630 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Eye is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Retinal Diseases and Treatments, Glaucoma and retinal disorders and Intraocular Surgery and Lenses, together about 27.5% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising ophthalmologist, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists. Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease oculo-plastic surgery orbital and lacrimal disease ocular surface and corneal disorders paediatric ophthalmology and strabismus glaucoma medical and surgical retina neuro-ophthalmology cataract and refractive surgery ocular oncology ophthalmic pathology ophthalmic genetics
From the journal's Aims & Scope
Research area (LetPub): Ophthalmology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Retinal Diseases and TreatmentsMedicine10.2%
- Glaucoma and retinal disordersMedicine9.9%
- Intraocular Surgery and LensesMedicine7.5%
- Retinal and Macular SurgeryMedicine6.8%
- Ophthalmology and Visual Impairment StudiesMedicine6.6%
- Corneal surgery and disordersMedicine5.4%
- Ocular Diseases and Behçet’s SyndromeMedicine4.9%
- Legal and Regulatory AnalysisSocial Sciences4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECINAHLCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, OCLC
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.42LetPub ·
- Impact factor (publisher) 2025
- 4.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.5Publisher website ·
- CiteScore 2026-06
- 6.1LetPub ·
- SJR 2026-06
- 1.25LetPub ·
- SNIP 2026-06
- 1.64LetPub ·
- h-index
- 86LetPub ·
- h-index
- 171OpenAlex ·
- i10-index
- 6,718OpenAlex ·
- 2-year mean citedness
- 2.92OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 37.03%LetPub ·
Volume
- Articles per year
- 358LetPub ·
- Downloads per year (publisher) 2025
- 6,930,188Publisher website ·
Articles by year OpenAlex count · 15,005 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 707 | 426 | 114 |
| 2025 | 630 | 459 | 1,297 |
| 2024 | 659 | 659 | 4,425 |
| 2023 | 517 | 517 | 5,158 |
| 2022 | 523 | 522 | 6,277 |
| 2021 | 523 | 516 | 9,022 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
67 daysMedian, submission to acceptance · P25–P75 34 days – 179 days
- Acceptance to online
- median 13 days (178 articles)
- Submission to online
- median 78 days
- Sample
- 178 articles with submission and acceptance dates (1,519 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,590 / EUR 5,290 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePublication ethics
- Publication ethics
Member of and subscribes to the principles of the Committee on Publication Ethics (COPE) Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1987
- ISSN
- 0950-222X
- Electronic ISSN
- 1476-5454
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Eye
What CAS zone is Eye in?
In the 2025 upgraded edition of the CAS Journal Ranking, Eye is in Zone 3 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Eye?
The latest impact factor listed by LetPub is 4.42; CiteScore 6.1, h-index 171.
How long does peer review take at Eye?
Based on the dates recorded on 178 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 34–179 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Eye?
According to LetPub and DOAJ records, Eye is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, CINAHL and Current Contents; that list has not been checked against each database.
Is Eye open access, and what is the APC?
Eye is a hybrid journal. For open-access publication: APC about USD 3,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .